{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:44:40Z","timestamp":1770893080728,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Philanthropic donation by Dolce & Gabbana fashion"},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2021-12374872-1"],"award-info":[{"award-number":["GR-2021-12374872-1"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020-12371640"],"award-info":[{"award-number":["COVID-2020-12371640"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020\u201312371617"],"award-info":[{"award-number":["COVID-2020\u201312371617"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020\u201312371617"],"award-info":[{"award-number":["COVID-2020\u201312371617"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020\u201312371617"],"award-info":[{"award-number":["COVID-2020\u201312371617"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020\u201312371617"],"award-info":[{"award-number":["COVID-2020\u201312371617"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NextGeneration EU-MUR PNRR","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40263-024-01081-4","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:02:31Z","timestamp":1713985351000},"page":"459-472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety"],"prefix":"10.1007","volume":"38","author":[{"given":"Rebecca","family":"De Lorenzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario G.","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Sciorati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Scavello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariagrazia","family":"Palladini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Merolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Rovere-Querini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo A.","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"issue":"6","key":"1081_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603\u20135. https:\/\/doi.org\/10.1001\/jama.2020.12603.","journal-title":"JAMA"},{"issue":"4","key":"1081_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601\u201315. https:\/\/doi.org\/10.1038\/s41591-021-01283-z.","journal-title":"Nat Med"},{"issue":"5","key":"1081_CR3","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/brain\/awab435","volume":"145","author":"S Huang","year":"2022","unstructured":"Huang S, Zhou Z, Yang D, Zhao W, Zeng M, Xie X, et al. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain. 2022;145(5):1830\u20138.","journal-title":"Brain"},{"issue":"2","key":"1081_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(21)00031-X","volume":"9","author":"P Venkatesan","year":"2021","unstructured":"Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. https:\/\/doi.org\/10.1016\/S2213-2600(21)00031-X.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"1081_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11417","volume":"4","author":"T Nasserie","year":"2021","unstructured":"Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients With COVID-19: a systematic review. JAMA Netw Open. 2021;4(5): e2111417. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.11417.","journal-title":"JAMA Netw Open"},{"key":"1081_CR6","doi-asserted-by":"publisher","unstructured":"Poletti S, Mazza MG, Calesella F, Vai B, Lorenzi C, Manfredi E, et al. Circulating inflammatory markers impact cognitive functions in bipolar depression. J Psychiatr Res. 2021;140:110\u20136. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.05.071.","DOI":"10.1016\/j.jpsychires.2021.05.071"},{"key":"1081_CR7","doi-asserted-by":"publisher","unstructured":"Benedetti F, Poletti S, Vai B, Mazza MG, Lorenzi C, Brioschi S, et al. Higher baseline interleukin-1beta and TNF-alpha hamper antidepressant response in major depressive disorder. Eur Neuropsychopharmacol. 2021;42:35\u201344. https:\/\/doi.org\/10.1016\/j.euroneuro.2020.11.009.","DOI":"10.1016\/j.euroneuro.2020.11.009"},{"key":"1081_CR8","doi-asserted-by":"publisher","unstructured":"Mazza MG, Palladini M, Villa G, De Lorenzo R, Rovere Querini P, Benedetti F. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J Psychiatr Res. 2022;155:112\u20139. https:\/\/doi.org\/10.1016\/j.jpsychires.2022.08.008.","DOI":"10.1016\/j.jpsychires.2022.08.008"},{"key":"1081_CR9","doi-asserted-by":"publisher","unstructured":"Manning K, Zvolensky MJ, Garey L, Long LJ, Gallagher MW. The explanatory role of fatigue severity in the relation between COVID-19 perceived stress and depression, anxiety, and panic severity. Cogn Behav Therapy. 2021:1-11. https:\/\/doi.org\/10.1080\/16506073.2021.1874503.","DOI":"10.1080\/16506073.2021.1874503"},{"key":"1081_CR10","doi-asserted-by":"publisher","unstructured":"Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34-9. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.027.","DOI":"10.1016\/j.bbi.2020.04.027"},{"issue":"283","key":"1081_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jad.2021.01.020","volume":"15","author":"M Passavanti","year":"2021","unstructured":"Passavanti M, Argentieri A, Barbieri DM, Lou B, Wijayaratna K, Foroutan Mirhosseini AS, et al. The psychological impact of COVID-19 and restrictive measures in the world. J Affect Disord. 2021;15(283):36\u201351. https:\/\/doi.org\/10.1016\/j.jad.2021.01.020.","journal-title":"J Affect Disord"},{"issue":"1","key":"1081_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011063","volume":"19","author":"R Kumar","year":"2023","unstructured":"Kumar R, Aktay-Cetin O, Craddock V, Morales-Cano D, Kosanovic D, Cogolludo A, et al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities. PLoS Pathog. 2023;19(1): e1011063. https:\/\/doi.org\/10.1371\/journal.ppat.1011063.","journal-title":"PLoS Pathog"},{"key":"1081_CR13","doi-asserted-by":"publisher","unstructured":"Maamar M, Artime A, Pariente E, Fierro P, Ruiz Y, Gutierrez S, et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022;38(6):901-9. https:\/\/doi.org\/10.1080\/03007995.2022.2042991.","DOI":"10.1080\/03007995.2022.2042991"},{"issue":"6","key":"1081_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000331","volume":"43","author":"G Saini","year":"2021","unstructured":"Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. BioEssays. 2021;43(6): e2000331. https:\/\/doi.org\/10.1002\/bies.202000331.","journal-title":"BioEssays"},{"issue":"7","key":"1081_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40263-022-00931-3","volume":"36","author":"MG Mazza","year":"2022","unstructured":"Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681\u2013702. https:\/\/doi.org\/10.1007\/s40263-022-00931-3.","journal-title":"CNS Drugs"},{"key":"1081_CR16","doi-asserted-by":"publisher","unstructured":"Porte R, Davoudian S, Asgari F, Parente R, Mantovani A, Garlanda C, et al. The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Front Immunol. 2019;10:794. https:\/\/doi.org\/10.3389\/fimmu.2019.00794.","DOI":"10.3389\/fimmu.2019.00794"},{"issue":"5","key":"1081_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","volume":"388","author":"A Mantovani","year":"2023","unstructured":"Mantovani A, Garlanda C. Humoral innate immunity and acute-phase proteins. N Engl J Med. 2023;388(5):439\u201352. https:\/\/doi.org\/10.1056\/NEJMra2206346.","journal-title":"N Engl J Med"},{"issue":"5","key":"1081_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000521612","volume":"14","author":"CB Hansen","year":"2022","unstructured":"Hansen CB, Sandholdt H, Moller MEE, Perez-Alos L, Pedersen L, Bastrup Israelsen S, et al. Prediction of respiratory failure and mortality in COVID-19 patients using long pentraxin PTX3. J Innate Immun. 2022;14(5):493\u2013501. https:\/\/doi.org\/10.1159\/000521612.","journal-title":"J Innate Immun"},{"key":"1081_CR19","doi-asserted-by":"publisher","unstructured":"Lapadula G, Leone R, Bernasconi DP, Biondi A, Rossi E, D'Angio M, et al. Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19. Front Immunol. 2022;13:933960; https:\/\/doi.org\/10.3389\/fimmu.2022.933960.","DOI":"10.3389\/fimmu.2022.933960"},{"issue":"2","key":"1081_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41590-021-01114-w","volume":"23","author":"M Stravalaci","year":"2022","unstructured":"Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23(2):275\u201386. https:\/\/doi.org\/10.1038\/s41590-021-01114-w.","journal-title":"Nat Immunol"},{"issue":"1","key":"1081_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-020-00832-x","volume":"22","author":"E Brunetta","year":"2021","unstructured":"Brunetta E, Folci M, Bottazzi B, De Santis M, Gritti G, Protti A, et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol. 2021;22(1):19\u201324. https:\/\/doi.org\/10.1038\/s41590-020-00832-x.","journal-title":"Nat Immunol"},{"issue":"2","key":"1081_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210\u20136. https:\/\/doi.org\/10.1038\/s41590-021-01113-x.","journal-title":"Nat Immunol"},{"issue":"10","key":"1081_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239570","volume":"15","author":"R De Lorenzo","year":"2020","unstructured":"De Lorenzo R, Conte C, Lanzani C, Benedetti F, Roveri L, Mazza MG, et al. Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study. PLoS One. 2020;15(10): e0239570. https:\/\/doi.org\/10.1371\/journal.pone.0239570.","journal-title":"PLoS One"},{"key":"1081_CR24","doi-asserted-by":"publisher","unstructured":"Farina N, Ramirez GA, De Lorenzo R, Di Filippo L, Conte C, Ciceri F, et al. COVID-19: Pharmacology and kinetics of viral clearance. Pharmacol Res. 2020;161:105114; https:\/\/doi.org\/10.1016\/j.phrs.2020.105114.","DOI":"10.1016\/j.phrs.2020.105114"},{"key":"1081_CR25","doi-asserted-by":"publisher","unstructured":"Rovere Querini P, De Lorenzo R, Conte C, Brioni E, Lanzani C, Yacoub MR, et al. Post-COVID-19 follow-up clinic: depicting chronicity of a new disease. Acta Biomed. 2020;91(9-S):22-8. https:\/\/doi.org\/10.23750\/abm.v91i9-S.10146.","DOI":"10.23750\/abm.v91i9-S.10146"},{"key":"1081_CR26","doi-asserted-by":"publisher","unstructured":"Rovere-Querini P, Tresoldi C, Conte C, Ruggeri A, Ghezzi S, R DEL, et al. Biobanking for COVID-19 research. Panminerva Med. 2022;64(2):244-52. https:\/\/doi.org\/10.23736\/S0031-0808.20.04168-3","DOI":"10.23736\/S0031-0808.20.04168-3"},{"key":"1081_CR27","doi-asserted-by":"publisher","unstructured":"De Lorenzo R, Magnaghi C, Cinel E, Vitali G, Martinenghi S, Mazza MG, et al. A Nomogram-based model to predict respiratory dysfunction at 6 months in non-critical COVID-19 survivors. Front Med (Lausanne). 2022;9:781410. https:\/\/doi.org\/10.3389\/fmed.2022.781410.","DOI":"10.3389\/fmed.2022.781410"},{"key":"1081_CR28","doi-asserted-by":"publisher","unstructured":"R Del, Cinel E, Cilla M, Compagnone N, Ferrante M, Falbo E, et al. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors. Panminerva Med. 2021. https:\/\/doi.org\/10.23736\/S0031-0808.21.04399-8.","DOI":"10.23736\/S0031-0808.21.04399-8"},{"key":"1081_CR29","doi-asserted-by":"publisher","unstructured":"First MB. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis. 2013;201(9):727-9. https:\/\/doi.org\/10.1097\/NMD.0b013e3182a2168a.","DOI":"10.1097\/NMD.0b013e3182a2168a"},{"issue":"1","key":"1081_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","volume":"12","author":"WW Zung","year":"1965","unstructured":"Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12(1):63\u201370. https:\/\/doi.org\/10.1001\/archpsyc.1965.01720310065008.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"1081_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/1097-4679(198411)40:6<1365::aid-jclp2270400615>3.0.co;2-d","volume":"40","author":"AT Beck","year":"1984","unstructured":"Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984;40(6):1365\u20137. https:\/\/doi.org\/10.1002\/1097-4679(198411)40:6%3c1365::aid-jclp2270400615%3e3.0.co;2-d.","journal-title":"J Clin Psychol"},{"issue":"12","key":"1081_CR32","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.brat.2003.07.010","volume":"41","author":"M Creamer","year":"2003","unstructured":"Creamer M, Bell R, Failla S. Psychometric properties of the impact of event scale\u2014revised. Behav Res Ther. 2003;41(12):1489\u201396. https:\/\/doi.org\/10.1016\/j.brat.2003.07.010.","journal-title":"Behav Res Ther"},{"issue":"3","key":"1081_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/00223890701885027","volume":"90","author":"F Vigneau","year":"2008","unstructured":"Vigneau F, Cormier S. The factor structure of the State-Trait Anxiety Inventory: an alternative view. J Pers Assess. 2008;90(3):280\u20135. https:\/\/doi.org\/10.1080\/00223890701885027.","journal-title":"J Pers Assess"},{"issue":"1","key":"1081_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s10020-021-00390-4","volume":"27","author":"NI Lore","year":"2021","unstructured":"Lore NI, De Lorenzo R, Rancoita PMV, Cugnata F, Agresti A, Benedetti F, et al. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study. Mol Med. 2021;27(1):129. https:\/\/doi.org\/10.1186\/s10020-021-00390-4.","journal-title":"Mol Med"},{"key":"1081_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized linear models","author":"P McCullagh","year":"1989","unstructured":"McCullagh P, Nelder JA. Generalized linear models. 2nd ed. New York: Chapman & Hall; 1989.","edition":"2"},{"key":"1081_CR36","volume-title":"An introduction to categorical data analysis","author":"A Agresti","year":"1996","unstructured":"Agresti A. An introduction to categorical data analysis. New York: Wiley; 1996."},{"key":"1081_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-7252-1","volume-title":"An introduction to generalized linear models","author":"AJ Dobson","year":"1990","unstructured":"Dobson AJ. An introduction to generalized linear models. New York: Chapman & Hall; 1990."},{"issue":"6","key":"1081_CR38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molmed.2016.04.007","volume":"22","author":"E Magrini","year":"2016","unstructured":"Magrini E, Mantovani A, Garlanda C. The dual complexity of PTX3 in health and disease: a balancing act? Trends Mol Med. 2016;22(6):497\u2013510. https:\/\/doi.org\/10.1016\/j.molmed.2016.04.007.","journal-title":"Trends Mol Med"},{"issue":"1","key":"1081_CR39","doi-asserted-by":"publisher","first-page":"18340","DOI":"10.1038\/s41598-019-54910-8","volume":"9","author":"SM Staubli","year":"2019","unstructured":"Staubli SM, Schafer J, Rosenthal R, Zeindler J, Oertli D, Nebiker CA. The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis. Sci Rep. 2019;9(1):18340. https:\/\/doi.org\/10.1038\/s41598-019-54910-8.","journal-title":"Sci Rep"},{"issue":"7836","key":"1081_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","volume":"588","author":"J Carvelli","year":"2020","unstructured":"Carvelli J, Demaria O, Vely F, Batista L, Chouaki Benmansour N, Fares J, et al. Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis. Nature. 2020;588(7836):146\u201350. https:\/\/doi.org\/10.1038\/s41586-020-2600-6.","journal-title":"Nature"},{"issue":"292","key":"1081_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2015.12.007","volume":"15","author":"I Rajkovic","year":"2016","unstructured":"Rajkovic I, Denes A, Allan SM, Pinteaux E. Emerging roles of the acute phase protein pentraxin-3 during central nervous system disorders. J Neuroimmunol. 2016;15(292):27\u201333. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.12.007.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"1081_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024371","volume":"6","author":"MA Bourgeois","year":"2011","unstructured":"Bourgeois MA, Denslow ND, Seino KS, Barber DS, Long MT. Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus. PLoS One. 2011;6(10): e24371. https:\/\/doi.org\/10.1371\/journal.pone.0024371.","journal-title":"PLoS One"},{"issue":"1","key":"1081_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1956","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hu H, Liu C, Wu J, Zhou S, Zhao T. Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis. Brain Behav. 2021;11(1): e01956. https:\/\/doi.org\/10.1002\/brb3.1956.","journal-title":"Brain Behav"},{"issue":"13","key":"1081_CR44","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/mds.23871","volume":"26","author":"HW Lee","year":"2011","unstructured":"Lee HW, Choi J, Suk K. Increases of pentraxin 3 plasma levels in patients with Parkinson\u2019s disease. Mov Disord. 2011;26(13):2364\u201370. https:\/\/doi.org\/10.1002\/mds.23871.","journal-title":"Mov Disord"},{"issue":"2","key":"1081_CR45","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2011.11.036","volume":"220","author":"WS Ryu","year":"2012","unstructured":"Ryu WS, Kim CK, Kim BJ, Kim C, Lee SH, Yoon BW. Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis. 2012;220(2):581\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.11.036.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1081_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3906\/sag-1211-90","volume":"44","author":"S Sezer","year":"2014","unstructured":"Sezer S, Ucar F, Ulusoy EK, Erdogan S, Bilen S, Zungun C, et al. Serum amyloid A, fetuin-A, and pentraxin-3 levels in patients with ischemic stroke: novel prognostic biomarkers? Turk J Med Sci. 2014;44(1):16\u201323. https:\/\/doi.org\/10.3906\/sag-1211-90.","journal-title":"Turk J Med Sci."},{"issue":"6","key":"1081_CR47","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19. J Infect. 2020;80(6):607\u201313. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.037.","journal-title":"J Infect"},{"key":"1081_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","volume":"53","author":"F Coperchini","year":"2020","unstructured":"Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25\u201332. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.003.","journal-title":"Cytokine Growth Factor Rev."},{"key":"1081_CR49","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbi.2018.02.003","volume":"69","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E. TNFalpha disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun. 2018;69:556\u201367. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.003.","journal-title":"Brain Behav Immun."},{"issue":"1","key":"1081_CR50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/physrev.00039.2016","volume":"98","author":"R Dantzer","year":"2018","unstructured":"Dantzer R. Neuroimmune Interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98(1):477\u2013504. https:\/\/doi.org\/10.1152\/physrev.00039.2016.","journal-title":"Physiol Rev"},{"key":"1081_CR51","doi-asserted-by":"publisher","unstructured":"Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflamm. 2013;10:43; https:\/\/doi.org\/10.1186\/1742-2094-10-43","DOI":"10.1186\/1742-2094-10-43"},{"issue":"1","key":"1081_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22\u201334. https:\/\/doi.org\/10.1038\/nri.2015.5.","journal-title":"Nat Rev Immunol"},{"key":"1081_CR53","doi-asserted-by":"publisher","unstructured":"Benedetti F, Aggio V, Pratesi ML, Greco G, Furlan R. Neuroinflammation in bipolar depression. Front Psychiatry. 2020;11:71. https:\/\/doi.org\/10.3389\/fpsyt.2020.00071","DOI":"10.3389\/fpsyt.2020.00071"},{"issue":"1\u20132","key":"1081_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0165-5728(00)00214-9","volume":"106","author":"N Polentarutti","year":"2000","unstructured":"Polentarutti N, Bottazzi B, Di Santo E, Blasi E, Agnello D, Ghezzi P, et al. Inducible expression of the long pentraxin PTX3 in the central nervous system. J Neuroimmunol. 2000;106(1\u20132):87\u201394. https:\/\/doi.org\/10.1016\/s0165-5728(00)00214-9.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"1081_CR55","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696\u2013709. https:\/\/doi.org\/10.1038\/mp.2016.3.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1081_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/schbul\/sbx035","volume":"44","author":"AK Wang","year":"2018","unstructured":"Wang AK, Miller BJ. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. 2018;44(1):75\u201383. https:\/\/doi.org\/10.1093\/schbul\/sbx035.","journal-title":"Schizophr Bull"},{"key":"1081_CR57","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang J, Ye Y, Zou Y, Chen W, Wang Z, et al. Peripheral cytokine levels across psychiatric disorders: a systematic review and network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2023;125:110740. https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110740.","DOI":"10.1016\/j.pnpbp.2023.110740"},{"key":"1081_CR58","doi-asserted-by":"publisher","first-page":"740686","DOI":"10.3389\/fphys.2021.740686","volume":"12","author":"F Benedetti","year":"2021","unstructured":"Benedetti F, Dallaspezia S, Melloni EMT, Lorenzi C, Zanardi R, Barbini B, et al. Effective antidepressant chronotherapeutics (sleep deprivation and light therapy) normalize the IL-1beta:IL-1ra ratio in bipolar depression. Front Physiol. 2021;12:740686. https:\/\/doi.org\/10.3389\/fphys.2021.740686.","journal-title":"Front Physiol."},{"issue":"202","key":"1081_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2016.05.047","volume":"15","author":"F Benedetti","year":"2016","unstructured":"Benedetti F, Poletti S, Hoogenboezem TA, Mazza E, Ambree O, de Wit H, et al. Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder. J Affect Disord. 2016;15(202):1\u20139. https:\/\/doi.org\/10.1016\/j.jad.2016.05.047.","journal-title":"J Affect Disord"},{"issue":"11","key":"1081_CR60","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1517\/14728222.2012.718331","volume":"16","author":"M Maes","year":"2012","unstructured":"Maes M, Song C, Yirmiya R. Targeting IL-1 in depression. Expert Opin Ther Targets. 2012;16(11):1097\u2013112. https:\/\/doi.org\/10.1517\/14728222.2012.718331.","journal-title":"Expert Opin Ther Targets."},{"key":"1081_CR61","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","volume":"89","author":"MG Mazza","year":"2020","unstructured":"Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594\u2013600. https:\/\/doi.org\/10.1016\/j.bbi.2020.07.037.","journal-title":"Brain Behav Immun."},{"key":"1081_CR62","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbi.2021.02.021","volume":"94","author":"MG Mazza","year":"2021","unstructured":"Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138\u201347. https:\/\/doi.org\/10.1016\/j.bbi.2021.02.021.","journal-title":"Brain Behav Immun."},{"issue":"145","key":"1081_CR63","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jpsychires.2021.11.031","volume":"22","author":"MG Mazza","year":"2021","unstructured":"Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, et al. 1-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res. 2021;22(145):118\u201324. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.11.031.","journal-title":"J Psychiatr Res"},{"key":"1081_CR64","doi-asserted-by":"crossref","unstructured":"Poletti S, Paolini M, Mazza MG, Palladini M, Furlan R, Querini PR, et al. Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors: Glutathione in COVID-19. Eur Neuropsychopharm. 2022.","DOI":"10.1016\/j.euroneuro.2022.06.008"},{"key":"1081_CR65","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3389\/fimmu.2019.01750","volume":"10","author":"K Haapasalo","year":"2019","unstructured":"Haapasalo K, Meri S. Regulation of the complement system by pentraxins. Front Immunol. 2019;10:1750. https:\/\/doi.org\/10.3389\/fimmu.2019.01750.","journal-title":"Front Immunol."},{"issue":"1","key":"1081_CR66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.npp.1300307","volume":"29","author":"RC Shelton","year":"2004","unstructured":"Shelton RC, Liang S, Liang P, Chakrabarti A, Manier DH, Sulser F. Differential expression of pentraxin 3 in fibroblasts from patients with major depression. Neuropsychopharmacology. 2004;29(1):126\u201332. https:\/\/doi.org\/10.1038\/sj.npp.1300307.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1081_CR67","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/acps.12451","volume":"132","author":"F Dickerson","year":"2015","unstructured":"Dickerson F, Katsafanas E, Schweinfurth LA, Savage CL, Stallings C, Origoni A, et al. Immune alterations in acute bipolar depression. Acta Psychiatr Scand. 2015;132(3):204\u201310. https:\/\/doi.org\/10.1111\/acps.12451.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"1081_CR68","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.bbi.2011.03.013","volume":"25","author":"RC Drexhage","year":"2011","unstructured":"Drexhage RC, Hoogenboezem TH, Versnel MA, Berghout A, Nolen WA, Drexhage HA. The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun. 2011;25(6):1206\u201313. https:\/\/doi.org\/10.1016\/j.bbi.2011.03.013.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"1081_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/bdi.12281","volume":"17","author":"F Dickerson","year":"2015","unstructured":"Dickerson F, Stallings C, Origoni A, Katsafanas E, Schweinfurth LA, Savage CL, et al. Pentraxin 3 is reduced in bipolar disorder. Bipolar Disord. 2015;17(4):409\u201314. https:\/\/doi.org\/10.1111\/bdi.12281.","journal-title":"Bipolar Disord"},{"issue":"8","key":"1081_CR70","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/gerona\/glz217","volume":"75","author":"LM Miller","year":"2020","unstructured":"Miller LM, Jenny NS, Rawlings AM, Arnold AM, Fitzpatrick AL, Lopez OL, et al. Sex differences in the association between pentraxin 3 and cognitive decline: the cardiovascular health study. J Gerontol A Biol Sci Med Sci. 2020;75(8):1523\u20139. https:\/\/doi.org\/10.1093\/gerona\/glz217.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"1081_CR71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","journal-title":"Nat Rev Microbiol"},{"key":"1081_CR72","doi-asserted-by":"publisher","unstructured":"Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473-87; https:\/\/doi.org\/10.1080\/07853890.2022.2076901.","DOI":"10.1080\/07853890.2022.2076901"},{"issue":"3","key":"1081_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/YIC.0000000000000403","volume":"37","author":"F Benedetti","year":"2022","unstructured":"Benedetti F, Zanardi R, Mazza MG. Antidepressant psychopharmacology: is inflammation a future target? Int Clin Psychopharmacol. 2022;37(3):79\u201381. https:\/\/doi.org\/10.1097\/YIC.0000000000000403.","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"1081_CR74","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1007\/s12035-017-0632-1","volume":"55","author":"CA Kohler","year":"2018","unstructured":"Kohler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, et al. Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol. 2018;55(5):4195\u2013206. https:\/\/doi.org\/10.1007\/s12035-017-0632-1.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1081_CR75","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41380-021-01432-3","volume":"27","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto Y, Suzuki T, Hashimoto K. Mechanisms of action of fluvoxamine for COVID-19: a historical review. Mol Psychiatry. 2022;27(4):1898\u2013907. https:\/\/doi.org\/10.1038\/s41380-021-01432-3.","journal-title":"Mol Psychiatry"},{"key":"1081_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.genhosppsych.2022.12.002","volume":"80","author":"MG Mazza","year":"2023","unstructured":"Mazza MG, Palladini M, Villa G, Agnoletto E, Harrington Y, Vai B, et al. Prevalence of depression in SARS-CoV-2 infected patients: An umbrella review of meta-analyses. Gen Hosp Psychiatry. 2023;80:17\u201325. https:\/\/doi.org\/10.1016\/j.genhosppsych.2022.12.002.","journal-title":"Gen Hosp Psychiatry."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01081-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01081-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01081-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T16:37:45Z","timestamp":1715877465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01081-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01081-4","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"10 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to BB and CG), by the Italian Ministry of Health (grant GR-2021-12374872-1 to MGM), by the Italian Ministry of Health for COVID-19 (grants COVID-2020-12371640 to CG and COVID-2020\u201312371617 to FC, FB, PR-Q, and AAM), by EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT, to CG), and by a COVID-19 program project grant from the IRCCS San Raffaele Hospital (to FC, FB, PR-Q, and AAM).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The COVID-BioB and the PT-COVID study protocols, compliant with the 1964 Declaration of Helsinki and its later amendments, were approved by the Hospital Ethics Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients signed informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"MGM, RDL, and CS designed the study. MGM, RDL, MP, AM, and FB examined the patients and collected clinical and laboratory data. CS, RL, FS, BB, and CG analyzed the biomarkers. MGM and RDL performed the statistical analyses and wrote the first draft. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}